2 results
Approved WMOSuspended
In an effort to collect safety and effectiveness information on the stent, Medlogics is conducting the Cobra II study.
Approved WMOCompleted
To assess uptake of 11C-osimertinib in tumor lesions of T790M double positive patients and T790M double negative patients, thereby evaluating specific and aspecific (off-target) 11C-osimertinib accumulation in tumor tissue.